We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Without Plaques, Alzheimer's Mice Recover

By Biotechdaily staff writers
Posted on 01 Feb 2005
The brain cells in a mouse model of Alzheimer's disease (AD) recovered rapidly after the characteristic brain plaques were removed, according to a new study conducted by researchers at Washington University School of Medicine (St. More...
Louis, MO, USA).

The researchers injected the mice with an antibody for a key component of brain plaques, the amyloid beta (Abeta) pepide. In areas where the antibodies cleared the plaques, many of the swellings observed on nerve cell branches rapidly disappeared. Prior to the experiment, many scientists believed plaque damage to nerve cells was something that only needed to happen once. The new findings suggest that the plaques might not only cause damage but also actively maintain it.

The mice used in the study had two mutations. One caused amyloid plaques to build up, while the second caused some of the mouse brain to produce a dye that allowed researchers to obtain detailed images of nerve cell branches. To correlate brain cell changes with plaque development, another dye was injected that temporarily sticks to amyloid. As the plaques appeared, nearby branches of nerve cells developed bumps and swellings. The swellings make it difficult or impossible for nerve-cell branches to send signals.

After showing that the number and size of the swellings were stable over the course of three to seven days, the Abeta antibodies were injected directly on the surface of the mouse brains. The plaques were cleared, and the swellings were monitored for three days. By then, there were no new swellings and there were 20-25% reductions in the number and size of the existing swellings. The largest swellings were least likely to heal.

"This provides confirmation of the potential benefits of plaque-clearing treatments and also gets us rethinking our theories on how plaques cause nerve-cell damage,” commented David H. Holzman, M.D., professor and head of the department of neurology at Washington University School of Medicine. The results of the study appear in the February 5, 2005, issue of the Journal of Clinical Investigation.




Related Links:
Washington U. Medical School

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Repetitive Pipette
VWR® Stepper Pro
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.